These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 8624462)

  • 21. Use of quantitative polymerase chain reaction to monitor residual disease in chronic myelogenous leukemia during treatment with interferon.
    Lion T; Gaiger A; Henn T; Hörth E; Haas OA; Geissler K; Gadner H
    Leukemia; 1995 Aug; 9(8):1353-60. PubMed ID: 7643624
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Minimal residual disease is more common in patients who have mixed T-cell chimerism after bone marrow transplantation for chronic myelogenous leukemia.
    Mackinnon S; Barnett L; Heller G; O'Reilly RJ
    Blood; 1994 Jun; 83(11):3409-16. PubMed ID: 8193379
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical value of quantitative long-term assessment of bcr-abl chimeric transcript in chronic myelogenous leukemia patients after allogeneic bone marrow transplantation.
    Martinelli G; Montefusco V; Testoni N; Amabile M; Saglio G; Ottaviani E; Terragna C; Bonifazi F; Rosti G; Bandini G; Tura S
    Haematologica; 2000 Jun; 85(6):653-8. PubMed ID: 10870124
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The evolving role of bone marrow transplantation in the treatment of chronic myelogenous leukemia.
    Delage R; Ritz J; Anderson KC
    Hematol Oncol Clin North Am; 1990 Apr; 4(2):369-88. PubMed ID: 2182597
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Myeloid mixed chimerism is associated with relapse in bcr-abl positive patients after unmanipulated allogeneic bone marrow transplantation for chronic myelogenous leukemia.
    Román J; Serrano J; Jiménez A; Castillejo JA; Reina ML; González MG; Rodríguez MC; García I; Sánchez J; Maldonado J; Torres A
    Haematologica; 2000 Feb; 85(2):173-80. PubMed ID: 10681725
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Minimal residual disease in chronic myeloid leukaemia.
    Cross NC
    Hematol Cell Ther; 1998 Oct; 40(5):224-8. PubMed ID: 9844816
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Survey of early disapearance of BCR/ABL fusion transcript after allogeneic or autologous stem cell transplantation for chronic myelogenous leukemia.
    Vey N; Balatzentko G; Lafage M; Sainty D; Bouabdallah R; Chabannon C; Blaise D; Gastaut JA; Gabert J
    Leuk Lymphoma; 2001; 42(5):945-52. PubMed ID: 11697649
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Early detection of relapse after bone marrow transplantation in patients with chronic myelogenous leukaemia.
    Lion T; Henn T; Gaiger A; Kalhs P; Gadner H
    Lancet; 1993 Jan; 341(8840):275-6. PubMed ID: 8093920
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Minimal residual disease in chronic myeloid leukemia in patients with long survival after allogeneic bone marrow transplantation].
    García A; Román J; Brunet S; Andrés P; Baiget M; Torres A
    Med Clin (Barc); 1995 Mar; 104(11):401-6. PubMed ID: 7715257
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular quantification of residual disease in chronic myelogenous leukemia after bone marrow transplantation.
    Thompson JD; Brodsky I; Yunis JJ
    Blood; 1992 Mar; 79(6):1629-35. PubMed ID: 1547352
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Minimal residual disease status in transplanted chronic myelogenous leukemia patients: low incidence of polymerase chain reaction positive cases among 48 long disease-free subjects who received unmanipulated allogeneic bone marrow transplants.
    Guerrasio A; Martinelli G; Saglio G; Rosso C; Zaccaria A; Rosti G; Testoni N; Ambrosetti A; Izzi T; Sessarego M
    Leukemia; 1992 Jun; 6(6):507-12. PubMed ID: 1602789
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic significance of genetic markers in chronic myelogenous leukemia patients after bone marrow transplantation.
    Zámecníková A; Kri an P; Mistrík M
    Neoplasma; 2000; 47(5):299-302. PubMed ID: 11130247
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Detection of minimal residual disease after allogeneic bone marrow transplantation in chronic myeloid leukemia].
    Liu Y; Fu J; Yu X; Chang Y; Xue W; Chen S; Lu D
    Zhonghua Xue Ye Xue Za Zhi; 1997 Mar; 18(3):140-2. PubMed ID: 15622775
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Frequent detection of BCR-ABL specific mRNA in patients with chronic myeloid leukemia (CML) following allogeneic and syngeneic bone marrow transplantation (BMT).
    Gaiger A; Lion T; Kalhs P; Mitterbauer G; Henn T; Haas O; Födinger M; Kier P; Forstinger C; Quehenberger P
    Leukemia; 1993 Nov; 7(11):1766-72. PubMed ID: 8231244
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Persistent donor chimaerism is consistent with disease-free survival following BMT for chronic myeloid leukaemia.
    Gardiner N; Lawler M; O'Riordan J; DeArce M; Humphries P; McCann SR
    Bone Marrow Transplant; 1997 Aug; 20(3):235-41. PubMed ID: 9257892
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Persistence of dormant leukemic progenitors during interferon-induced remission in chronic myelogenous leukemia. Analysis by polymerase chain reaction of individual colonies.
    Talpaz M; Estrov Z; Kantarjian H; Ku S; Foteh A; Kurzrock R
    J Clin Invest; 1994 Oct; 94(4):1383-9. PubMed ID: 7929813
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Early detection of relapse by hypermetaphase fluorescence in situ hybridization after allogeneic bone marrow transplantation for chronic myeloid leukemia.
    Seong CM; Giralt S; Kantarjian H; Xu J; Swantkowski J; Hayes K; Glassman AB; Khouri I; Korbling M; Thall P; Siciliano MJ; Champlin RE
    J Clin Oncol; 2000 May; 18(9):1831-6. PubMed ID: 10784623
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Detection of minimal residual disease in Philadelphia chromosome positive acute lymphoblastic leukemia: rationale for bone marrow transplantation from the polymerase chain reaction point of view.
    Miyamura K; Takeo T; Kataoka T; Tahara T; Tanimoto M; Saito H
    Leuk Lymphoma; 1993 Oct; 11(3-4):181-9. PubMed ID: 8260893
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cytogenetic and molecular detection of residual leukemic cells after allogeneic bone marrow transplantation in chronic granulocytic leukemia.
    Graham DL; Tefferi A; Letendre L; Gastineau DA; Hoagland HC; Noël P
    Mayo Clin Proc; 1992 Feb; 67(2):123-7. PubMed ID: 1545574
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Donor chimaerism is a strong indicator of disease free survival following bone marrow transplantation for chronic myeloid leukaemia.
    Gardiner N; Lawler M; O'Riordan J; De'Arce M; McCann SR
    Leukemia; 1997 Apr; 11 Suppl 3():512-5. PubMed ID: 9209441
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.